Patient Pathfinder: Clinical Trials
Clinical Trials for Hypertrophic Cardiomyopathy
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 29 active Hypertrophic Cardiomyopathy trials
Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCM
Study Type: Interventional Phase 3
Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM
Study Type: Interventional Phase 1
Exercise Intolerance in Non-obstructive Hypertrophic Cardiomyopathy
Study Type: Interventional
A Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy
Study Type: Interventional Phase 3
Sleep Apnea and Hypertrophic Cardiomyopathy (HCM)
Study Type: Observational
A Study to Evaluate the Efficacy, Safety, and Tolerability of MYK-224 in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Study Type: Interventional Phase 2
A Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive HCM Who Are Eligible for Septal Reduction Therapy
Study Type: Interventional Phase 3
Gene Therapy for Male Patients With Danon Disease (DD) Using RP-A501; AAV9.LAMP2B
Study Type: Interventional Phase 1
There are 29 active Hypertrophic Cardiomyopathy trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now